Literature DB >> 6282912

A very precise high-performance liquid chromatographic procedure for the determination of cefmenoxime, a new cephalosporin antibiotic, in plasma.

G R Granneman, L T Sennello.   

Abstract

A simple and very precise high-performance liquid chromatographic procedure has been developed for the determination of cefmenoxime, a new broad spectrum cephalosporin antibiotic, in plasma. The workup procedure involves ultrafiltration of samples which have been treated with sodium dodecyl sulfate to displace the drug from its binding sites on plasma proteins. The ultrafiltrates are then directly injected into a high-performance liquid chromatographic system utilizing a reversed-phase analytical column, and an ultraviolet spectrophotometric detector. The mean assay coefficient of variation over a concentration range of 0.5-200 micrograms/ml is slightly greater than 1% when either p-nitrobenzoic or p-anisic acid is used as the internal standard. Recoveries of drug are essentially quantitative at all levels investigated; hence the calibration curves are rectilinear from the limit of quantification (about 0.05 microgram/ml) to at least 200 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282912     DOI: 10.1016/s0378-4347(00)86046-6

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Cephalosporin assays.

Authors:  J B Ward; P B Harper
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Recent analytical methods for cephalosporins in biological fluids.

Authors:  R D Toothaker; D S Wright; L A Pachla
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

3.  Effect of probenecid on the pharmacokinetics of cefmenoxime.

Authors:  L T Sennello; D Quinn; D E Rollins; K G Tolman; R C Sonders
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

Review 4.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

5.  Metabolism of [14C]Cefmenoxime in normal subjects after intramuscular administration.

Authors:  J M Machinist; B A Bopp; D Quinn
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.